Accepted for/Published in: JMIR Formative Research
Date Submitted: Jun 3, 2023
Open Peer Review Period: Jun 3, 2023 - Jul 29, 2023
Date Accepted: Feb 14, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
New Technologies In Oncohematology: The Oncohemto-Nootric Program.
ABSTRACT
Background:
In oncohematological patients, the development of the disease and antineoplastic treatment have a high prevalence of adverse effects that compromise their physical and nutritional status
Objective:
In the era of digital transformation, we have launched a pioneering project in oncohematology patients to promote adherence to a healthy lifestyle and improve their quality of life by involving doctors and nutritionists through the Nootric App.
Methods:
We designed a prospective observational study that included twenty-two adult patients undergoing chemotherapy from March 2022 to May 2022, with a 12-week follow-up. They received physical-nutritional education. Sociodemographic, clinical-biological, healthcare impact, usability, and adherence data were collected
Results:
The most frequent hematologic disorders were lymphoproliferative syndromes and multiple myeloma. The clinical-biological parameters did not worsen. There were no admissions due to gastrointestinal toxicity or treatment discontinuations due to alterations in physical-nutritional well-being. Unscheduled consultations increased by only 5.5%. Over 50% of the patients improved their physical-nutritional habits, resulting in a significant impact on their quality of life.
Conclusions:
: E-health programs for nutrition and well-being in oncohematology patients provide value in the management of these conditions. Their implementation in routine clinical practice could be cost-effective in the short and long term. Clinical Trial: NA
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.